


| Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 |
|
"We are pleased to announce this amendment which leverages our partner Aurigene's expertise and resources to support the clinical advancement of CA-170, as well as maintain our rights to CA-170 outside of Asia ," said James Dentzer , President and Chief Executive Officer of Curis.
Posted: 2020-02-06 14:43:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.